Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute myocardial injury) and chronic damage to the cardiovascular system. Therefore, cardiovascular protection may be necessary when treating patients with COVID-19 infection. This may especially be necessary in patients with cardiovascular diseases, risk factors, and co-medication.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Assessment of cardiovascular diseases and cardiovascular risk factors | Diagnostic Test | At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication. |
| Measure | Description | Time Frame |
|---|---|---|
| All-cause mortality | mortality of any cause | During 1 year follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| 30-day mortality | mortality of any cause | Within 30 days after inclusion |
| Major adverse cardiovascular events | Myocardial infarction, stroke, or CV death |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The registry will include consecutive patients, tested for suspected SARS-CoV2/Covid-19 infection at the University Hospital Essen
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tienush Rassaf, MD | University Hospital Essen, Deparment of Cardiology and Vascular Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Essen | Essen | North Rhine-Westphalia | 45147 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36776683 | Derived | Mahabadi AA, Mincu R, Dykun I, Michel L, Kung A, Witzke O, Kill C, Buer J, Rassaf T, Totzeck M. Frequency and prognosis of CVD and myocardial injury in patients presenting with suspected COVID-19 - The CoV-COR registry. Int J Cardiol Heart Vasc. 2023 Apr;45:101184. doi: 10.1016/j.ijcha.2023.101184. Epub 2023 Feb 6. |
Not provided
Not provided
Will be made available upon request
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| During 1 year follow-up |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided